Literature DB >> 29629196

A comprehensive protocol for physiokinesis therapy and enhanced recovery after surgery in patients undergoing video-assisted thoracoscopic surgery lobectomy.

Alessandro Bertani1, Paolo Ferrari2, Danilo Terzo3, Emanuele Russo1, Gaetano Burgio4, Lavinia De Monte1, Francesco Raffaele1, Andrea Droghetti5, Roberto Crisci6.   

Abstract

BACKGROUND: Video-assisted thoracoscopic surgery (VATS) lobectomy has recently been adopted as the gold standard surgical option for the treatment of early stage non-small cell lung cancer. Enhanced recovery after surgery (ERAS) is being progressively adopted in thoracic surgery to improve the postoperative outcomes. Even if the benefits of ERAS are universally accepted, to date a standardized and uniform approach has not been described in the medical literature. The Italian VATS group has recently proposed to include in the VATS lobectomy database a structured protocol for ERAS.
METHODS: The ERAS section of the Italian VATS group is proposing a comprehensive ERAS protocol within the VATS lobectomy database, allowing the prospective collection of a dedicated set of data. Separate sections of the protocol are dedicated to different topics of ERAS. This study is specifically dedicated to the section of physiokinesis therapy. The medical literature will be extensively reviewed and a physiotherapy (PT) protocol of ERAS will be presented and discussed. A seta of structured clinical pathways will also be suggested for adoption in the VATS Group database. DISCUSSION: Pre- and post-operative adoption of an ERAS protocol in patients undergoing VATS lobectomy may promote an improved post-operative course, a shorter hospital stay and an overall more comfortable patients' experience. The mainstays of a physiokinesis therapy ERAS protocol are patients' education, constant physical and respiratory therapy sessions, and adoption of adequate devices. Although many studies have investigated the usefulness of physical and respiratory physiokinesis therapy, a comprehensive ERAS protocol for VATS lobectomy patients has not yet been described. The proposed ERAS platform, adopted by the VATS Group database, will contribute to a prospective data collection and allow a scientific analysis of the results.

Entities:  

Keywords:  Physical therapy; enhanced recovery after surgery (ERAS); respiratory therapy

Year:  2018        PMID: 29629196      PMCID: PMC5880990          DOI: 10.21037/jtd.2018.02.55

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  70 in total

1.  Effects of respiratory muscle work on exercise performance.

Authors:  C A Harms; T J Wetter; C M St Croix; D F Pegelow; J A Dempsey
Journal:  J Appl Physiol (1985)       Date:  2000-07

2.  Impact of a pre-operative pulmonary rehabilitation program on functional performance in patients undergoing video-assisted thoracic surgery for lung cancer.

Authors:  Raquel Sebio; Maria I Yáñez-Brage; Esther Giménez-Moolhuyzen; Marie C Valenza; Gregory Reychler; Larry P Cahalin
Journal:  Arch Bronconeumol       Date:  2015-12-30       Impact factor: 4.872

3.  Prophylactic use of noninvasive ventilation in patients undergoing lung resectional surgery.

Authors:  Christophe Perrin; Valérie Jullien; Nicolas Vénissac; Frédéric Berthier; Bernard Padovani; Françoise Guillot; Alain Coussement; Jérôme Mouroux
Journal:  Respir Med       Date:  2007-01-25       Impact factor: 3.415

4.  Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study.

Authors:  Martijn A Spruit; Paul P Janssen; Sonja C P Willemsen; Monique M H Hochstenbag; Emiel F M Wouters
Journal:  Lung Cancer       Date:  2006-03-09       Impact factor: 5.705

5.  Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.

Authors:  Subroto Paul; Nasser K Altorki; Shubin Sheng; Paul C Lee; David H Harpole; Mark W Onaitis; Brendon M Stiles; Jeffrey L Port; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02       Impact factor: 5.209

6.  Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.

Authors:  Bryan M Burt; Andrzej S Kosinski; Joseph B Shrager; Mark W Onaitis; Tracey Weigel
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-13       Impact factor: 5.209

7.  Postoperative pulmonary complications and rehabilitation requirements following lobectomy: a propensity score matched study of patients undergoing video-assisted thoracoscopic surgery versus thoracotomy†.

Authors:  Paula Agostini; Sebastian T Lugg; Kerry Adams; Nelia Vartsaba; Maninder S Kalkat; Pala B Rajesh; Richard S Steyn; Babu Naidu; Alison Rushton; Ehab Bishay
Journal:  Interact Cardiovasc Thorac Surg       Date:  2017-06-01

8.  Effects of a clinical pathway for video-assisted thoracoscopic surgery (VATS) on quality and cost of care.

Authors:  Matthias H M Schwarzbach; Ulrich Ronellenfitsch; Qian Wang; Eric D Rössner; Christof Denz; Stefan Post; Peter Hohenberger
Journal:  Langenbecks Arch Surg       Date:  2009-06-10       Impact factor: 3.445

9.  ["Fast-track" rehabilitation in thoracic surgery. First experiences with a multimodal, interdisciplinary, and proven perioperative treatment course].

Authors:  J I Gregor; W Schwenk; J Mall; M Kilian; C Spies; A Bloch; J M Müller; J C Rückert
Journal:  Chirurg       Date:  2008-07       Impact factor: 0.955

10.  Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD.

Authors:  Milos Petrovic; Michael Reiter; Harald Zipko; Wolfgang Pohl; Theodor Wanke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-11-30
View more
  1 in total

Review 1.  Essentials of Physiotherapy after Thoracic Surgery: What Physiotherapists Need to Know. A Narrative Review.

Authors:  Ahmad Mahdi Ahmad
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2018-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.